ADIL — Adial Pharmaceuticals, Inc.

ADILAdial Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · adial.com

2.450USD+1.24%Mkt Cap: 5.25M USDP/E: —Last update: 2026-06-01

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap5.25M USD

Enterprise Value-3.84M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-7.98M USD

Revenue/Share—

Last Price2.450 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees5

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.96

PEG—

EV/EBITDA0.49

EV/Revenue—

P/S—

P/B0.51

EPS (TTM)-4.89

EPS (Forward)-2.49

52W Range

1.3106% of range19.00

52W High19.00 USD

52W Low1.310 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-151.18%

ROA-119.54%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.49M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-71.75%

Net Debt-5.88M USD

Net Debt/EBITDA0.75

Balance Sheet

Debt/Equity—

Current Ratio4.42

Quick Ratio4.21

Book Value/Sh4.749 USD

Cash/Share4.119 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateFeb 6, 2026

Analyst Consensus

Rating—

Target (Mean)25.00 USD

Target Range8.000 USD – 42.00 USD

# Analysts2

Ownership

Shares Out.2.14M

Float1.28M

Insiders7.99%

Institutions9.89%

Short Interest

Short Ratio0.6d

Short % Float3.46%

Short % Out.3.43%

Shares Short49.01K

Short (prev mo.)79.61K

Technical

SMA 501.702 (+43.9%)

SMA 2005.590 (-56.2%)

Beta1.27

S&P 52W Chg27.94%

Avg Vol (30d)173.28K

Avg Vol (10d)328.73K

Technical Indicators

RSI (14)69.7

MACD0.1919

MACD Signal0.0931

MACD Hist.+0.0988

BB Upper2.618 USD

BB Middle1.792 USD

BB Lower0.9652 USD

BB Width92.26%

ATR (14)0.1944 USD

Vol Ratio (20d)0.16x